Abstract: The compounds of the general formula (I) in which X is represents two hydrogen atoms, a ?-bond, oxygen or methylene: R2 is a C6-C12 aryl, or arylalkyl residue: R3 is hydrogen, 2-hydroxyethyl or 2-aminoethyl are useful for the treatment of pathologies mediated by vanilloid receptors type I.
Type:
Grant
Filed:
July 6, 2005
Date of Patent:
September 30, 2008
Assignee:
Indena S.p.A.
Inventors:
Paolo Morazzoni, Antonella Riva, Gabriele Fontana, Giovanni Appendino, Vincenzo Di Marzo
Abstract: The present invention relates to a Cynara scolymus extract with a high content of caffeoylquinic acids, and a composition containing said Cynara scolymus extract with a Phaseolus vulgaris extract. Said composition is useful in reducing obesity as it reduces cholesterol, triglycerides and blood glucose by sensitising the cells to insulin. This combination, when taken before meals, reduces the appetite, leading to a reduction in body weight. The extracts are preferably formulated in Oenothera biennis oil, fish oil, or oils rich in unsaturated ?-3 fatty acids.
Type:
Application
Filed:
March 5, 2008
Publication date:
September 11, 2008
Applicant:
INDENA S.P.A.
Inventors:
Ezio BOMBARDELLI, Gabriele Fontana, Andrea Giori, Paolo Morazzoni, Cesare Ponzone, Massimo Ronchi
Abstract: This invention relates to the combination of ?-amylase inhibitors prepared from Phaseolus vulgaris with ?-glucosidase inhibitors obtained from Salacia oblonga and other species. The ?-amylase inhibitor is accompanied by a quantity of lectins that reduces the amount of glucose originating from the starches present in the diet, and considerably reduces the appetite after repeated administration. The combination with ?-glucosidase inhibitors, such as extracts of Salacia or the thiosugars present in it, further reduce the blood glucose, acting synergically, and consequently reduce the synthesis of fats from carbohydrates.
Type:
Application
Filed:
March 5, 2008
Publication date:
September 11, 2008
Applicant:
INDENA S.P.A.
Inventors:
Ezio BOMBARDELLI, Paolo Morazzoni, Cesare Ponzone, Massimo Ronchi
Abstract: The present invention relates to a Cynara scolymus extract with a high caffeoylquinic acid content, obtainable by extraction from undried globe artichoke heads with alcohols having up to three carbon atoms.
Type:
Application
Filed:
March 5, 2008
Publication date:
September 11, 2008
Applicant:
INDENA S. P. A.
Inventors:
Ezio Bombardelli, Gabriele Fontana, Andrea Giori, Paolo Morazzoni, Cesare Ponzone, Massimo Ronchi
Abstract: The invention relates to a process for the preparation of 10-deacetyl-N-debenzoyl-paclitaxel (I) a synthon useful for the preparation of taxanes with antitumour activity, and intermediates for the preparation thereof. The invention also discloses a process for the preparation of Docetaxel starting from said compound of formula (I).
Type:
Application
Filed:
April 17, 2008
Publication date:
August 21, 2008
Applicant:
INDENA S.P.A.
Inventors:
Bruno GABETTA, Andrea Gambini, Ezio Bombardelli, Gabriele Fontana
Abstract: Pharmaceutical and cosmetic compositions for the protection of the skin from damages induced by sun radiations, containing ingredients of vegetable origin, in addition to conventional sun filters and excipients.
Abstract: Disclosed is a series of N-deacetylthiocolchicine derivatives of formula (I) in which: the linker is a bivalent straight or branched C1-C8 alkyl residue, C3-C8 cycloalkyl, a phenylene or heterocyclic C4-C6 ring; the G1 and G2 junctions, which can be the same or different, are —CO—, —COHN—, —CR2— groups in which R2 is hydrogen or a straight C1-C4 alkyl residue, or the G1-linker-G2 group is the —CO— group. The compounds of formula (I) have antiproliferative, antinflammatory, antiarthritic and antiviral activity.
Abstract: The invention relates to a process for the preparation of 10-deacetyl-N-debenzoyl-paclitaxel, a synthon useful for the preparation of taxanes with antitumour activity, and intermediates for the preparation thereof. The invention also discloses a process for the preparation of Docetaxel starting from said compound of formula (I).
Type:
Application
Filed:
October 7, 2005
Publication date:
July 10, 2008
Applicant:
INDENA S.P.A.
Inventors:
Bruno Gabetta, Andrea Gambini, Ezio Bombardelli, Gabriele Fontana
Abstract: Pharmaceutical compositions containing: extracts of Tribulus terrestris, Epimedium koreanum, Cinnamon cassia in the weight ratio of 1.5-3.5:1-2:0.1-0.4 respectively; and optionally arginine or a physiologically equivalent ester, salt or precursor thereof. The compositions are useful in the treatment of male and female sexual dysfunctions. A method of treatment using the pharmaceutical compositions is also described.
Type:
Application
Filed:
February 25, 2008
Publication date:
June 19, 2008
Applicant:
INDENA S.p.A
Inventors:
Ezio BOMBARDELLI, Paolo MORAZZONI, Antonella RIVA, Roberto SEGHIZZI
Abstract: Pharmaceutical and cosmetic compositions for the protection of the skin from damages induced by sun radiations, containing ingredients of vegetable origin, in addition to conventional sun filters and excipients.
Abstract: The invention relates to a process for the preparation of ferutinine (Ia) from Ferula spp extracts comprising basic hydrolysis of the extracts and treatment with p-pivaloyloxybenzoic acid.
Abstract: Pharmaceutical compositions containing: extracts of Tribulus terrestris, Epimedium koreanum, Cinnamon cassia in the weight ratio of 1.5-3.5:1-2:0.1-0.4 respectively; and optionally arginine or a physiologically equivalent ester, salt or precursor thereof. The compositions are useful in the treatment of male and female sexual dysfunctions. A method of treatment using the pharmaceutical compositions is also described.
Type:
Grant
Filed:
May 2, 2003
Date of Patent:
April 22, 2008
Assignee:
Indena S.p.A.
Inventors:
Ezio Bombardelli, Paolo Morazzoni, Antonella Riva, Roberto Seghizzi
Abstract: Pharmaceutical and cosmetic compositions for the prevention of skin aging, containing phospholipid complexes of extracts of Vitis vinifera, and phospholipid complexes of standardized extract from Centella asiatica.
Abstract: The present invention relates to the use of extracts of plants or fruits of the Lycium genus, in particular of Lycium barbarum, for the preparation of growth promoters for use in livestock.
Type:
Application
Filed:
July 20, 2005
Publication date:
March 27, 2008
Applicant:
INDENA S.P.A.
Inventors:
Andrea Giori, Gianpaolo Forni, Giancomo Mombelli
Abstract: A method for the use of lupin conglutin gamma or of proteins showing homology higher than 50% with lupin conglutin gamma, for the preparation of a medicament, food supplements or foods for the treatment of type II diabetes, pharmaceutical and nutritional compositions containing lupin conglutin gamma, and the use of lupin conglutin gamma as therapeutical agent, in particular as hypoglycemizing agent. Lupin conglutin gamma may be used in pure form or in form of extracts, mixtures or concentrates.
Abstract: A process for the preparation of 14?-hydroxy-baccatin III-1,14-carbonate useful for the preparation of novel taxane derivatives with antitumor activity.
Abstract: Pharmaceutical and cosmetic compositions for the prevention of skin aging, containing phospholipid complexes of extracts of Vitis vinifera, and phospholipid complexes of standardized extract from Centella asiatica.
Abstract: The invention relates to an improved process for the synthesis of 13-(N-Boc-?-isobutylserinyl)-14-?-hydroxybaccatin III-1,14-carbonate (I), wherein carbonation of the 1,14-hydroxy groups of the baccatin skeleton is carried out with bis(trichloromethylcarbonate and the 7-hydroxy group is protected with a trichloroacetyl group.
Abstract: Seco-baccatin III derivatives of formula: wherein R, R1-R4, R1 R?, R11 R?, and R111 R?? are disclosed herein; pharmaceutical compositions comprising seco-baccatin III derivative; and methods for treating cancer, arthritis, and inhibiting angiogenesis in an animal comprising administrating to a patient in need thereof a therapeutically effective amount of a seco-baccatin III derivative are disclosed.
Abstract: A process for the preparation of taxane derivatives by reacting 10-deacetylbaccatin III protected at the 7-and 1-positions with trichloroacetyl groups with a compound of formula and subsequent removal of the protective groups and hydrolysis of the oxazolidine ring.